p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration

Area of Science:

• Cell Biology
• Molecular Biology
• Signal Transduction

Background:

• Epidermal Growth Factor Receptor (EGFR) signaling is critical for cell growth and is tightly regulated by receptor internalization and degradation.
• The precise mechanisms controlling EGFR processing and their impact on cellular responses remain areas of active investigation.

Purpose of the Study:

• To investigate the role of p38 mitogen-activated protein kinase (MAPK) in the regulation of epidermal growth factor (EGF) receptor (EGFR) processing following ligand binding.
• To determine how p38 activity influences EGFR internalization, degradation, and subsequent downstream signaling events.

Main Methods:

• Utilized pharmacological inhibitors and RNA interference to block p38 MAPK activity.
• Analyzed EGFR internalization, degradation, phosphorylation status (specifically Y1045), and ubiquitination.
• Assessed cellular responses including proliferation and migration in intestinal epithelial cells expressing wild-type or mutant EGFR.

Main Results:

• p38 MAPK is required for efficient EGF-induced EGFR degradation, but not its internalization.
• Inhibition of p38 prevents EGF-stimulated Cbl ubiquitin ligase activity and EGFR ubiquitination.
• Internalized EGFR accumulates in caveolin-1-containing vesicles when p38 is inhibited, associated with loss of Y1045 phosphorylation.
• EGFR Y1045F mutants mimic p38 inhibition effects, increasing proliferation but not migration in response to EGF.

Conclusions:

• p38 MAPK acts as a crucial modulator of ligand-stimulated EGFR processing.
• EGFR degradation, regulated by p38 and Cbl, is essential for uncoupling EGFR-mediated proliferation and migration.
• These findings highlight the importance of EGFR processing in dictating the cellular outcomes of EGFR signaling.